Loading...
LifeTime and improving European healthcare through cell-based interceptive medicine.
Rajewsky, Nikolaus Almouzni, Geneviève Gorski, Stanislaw A Aerts, Stein Amit, Ido Bertero, Michela G Bock, Christoph Bredenoord, Annelien L Cavalli, Giacomo Chiocca, Susanna
Rajewsky, Nikolaus
Almouzni, Geneviève
Gorski, Stanislaw A
Aerts, Stein
Amit, Ido
Bertero, Michela G
Bock, Christoph
Bredenoord, Annelien L
Cavalli, Giacomo
Chiocca, Susanna
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-09-07
Submitted date
Files
Loading...
Open Access article
Adobe PDF, 3.79 MB
Other Titles
Abstract
Here we describe the LifeTime Initiative, which aims to track, understand and target human cells during the onset and progression of complex diseases, and to analyse their response to therapy at single-cell resolution. This mission will be implemented through the development, integration and application of single-cell multi-omics and imaging, artificial intelligence and patient-derived experimental disease models during the progression from health to disease. The analysis of large molecular and clinical datasets will identify molecular mechanisms, create predictive computational models of disease progression, and reveal new drug targets and therapies. The timely detection and interception of disease embedded in an ethical and patient-centred vision will be achieved through interactions across academia, hospitals, patient associations, health data management systems and industry. The application of this strategy to key medical challenges in cancer, neurological and neuropsychiatric disorders, and infectious, chronic inflammatory and cardiovascular diseases at the single-cell level will usher in cell-based interceptive medicine in Europe over the next decade.
Citation
Nature. 2020 Nov;587(7834):377-386. doi: 10.1038/s41586-020-2715-9. Epub 2020 Sep 7.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Other
Other
Language
en
Description
Series/Report no.
ISSN
EISSN
1476-4687
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International